Kyowa Kirin (OTCMKTS:KYKOF) Trading Down 4.5% – Time to Sell?

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) shares were down 4.5% during mid-day trading on Tuesday . The stock traded as low as $15.8450 and last traded at $15.8450. Approximately 1,957 shares changed hands during trading, an increase of 174% from the average daily volume of 714 shares. The stock had previously closed at $16.59.

Analyst Ratings Changes

Separately, The Goldman Sachs Group cut Kyowa Kirin to a “sell” rating in a research note on Tuesday. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Kyowa Kirin presently has a consensus rating of “Sell”.

Kyowa Kirin Price Performance

The stock has a 50-day moving average price of $15.87 and a two-hundred day moving average price of $16.28.

About Kyowa Kirin

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.